The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)
Recruiting · NCT07512856 · Interventional (participants receive a specific treatment) · Lead sponsor: Institute of HIV Research and Innovation Foundation, Thailand
View the official record on ClinicalTrials.gov →Interventions studied
Transgender-tailored Harm Reduction Service
What this trial is about
This study evaluates a comprehensive transgender-tailored harm reduction service for transgender women, transgender men, and non-binary individuals engaging in chemsex or substance use in Thailand, focusing on PrEP uptake, HIV/STI outcomes, mental health, and socio-legal impacts.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Self-identified transgender women, transgender men, or non-binary persons
- Age ≥18 years
- HIV-negative
- Engaged in chemsex or substance use within past 12 months
- Able to provide informed consent
Exclusion criteria
- Inability to communicate in Thai sufficiently to complete study procedures
Where it is running
1 location listed.
- Tangerine Clinic, Institute of HIV Research and Innovation - Pathum Wan, Bangkok, Thailand